(DBXX) Xtrackers - FTSE 100 Income - Ratings and Ratios
Equity Exposure, Diversification, Index Tracking
Description: DBXX Xtrackers - FTSE 100 Income
The Xtrackers - FTSE100 Income UCITS ETF (XETRA:DBXX) is an exchange-traded fund that tracks the Morningstar UK All Cap TME NR GBP Index, providing investors with exposure to the UK large-cap equity market. As a UCITS-compliant ETF, it adheres to stringent regulatory standards, ensuring a high level of investor protection.
Managed by DWS, a reputable asset management firm, the ETF is listed on the XETRA exchange, offering a convenient and liquid investment vehicle for investors seeking to gain exposure to the UK equity market. With a focus on income generation, this ETF is likely to appeal to investors seeking regular returns from their investments.
Analyzing the ETFs recent performance, we observe a steady upward trend, with the last price recorded at 10.15. The short-term (SMA20: 9.83) and long-term (SMA50: 9.76, SMA200: 9.69) moving averages indicate a strong bullish momentum. The Average True Range (ATR: 0.17 = 1.71%) suggests moderate volatility, which is relatively contained. Given the current price is near the 52W High (10.41), we can expect some consolidation or a potential pullback.
Combining the technical analysis with fundamental data, we note that the Assets Under Management (AUM: 63.21M EUR) indicate a relatively small but still viable fund size. Considering the ETFs objective to track the Morningstar UK All Cap TME NR GBP Index, which comprises a broad range of UK equities, we can anticipate that the ETFs performance will be closely tied to the overall UK equity market.
Forecasting the ETFs future performance, we can expect a continued upward trend, driven by the underlying indexs performance. However, given the current price proximity to the 52W High and moderate volatility, we may see some short-term consolidation. If the UK equity market continues to perform well, driven by factors such as economic growth and dividend yields, the ETF is likely to benefit, potentially reaching new highs. Conversely, any downturn in the UK equity market may negatively impact the ETFs performance. Based on the current technical and fundamental analysis, a potential price target for the ETF could be around 10.50, representing a 3.5% increase from the current price.
Additional Sources for DBXX ETF
DBXX ETF Overview
Market Cap in USD | 75m |
Category | UK Large-Cap Equity |
TER | 0.09% |
IPO / Inception | 2007-06-05 |
DBXX ETF Ratings
Growth Rating | 70.7 |
Fundamental | - |
Dividend Rating | 42.3 |
Rel. Strength | -17.9 |
Analysts | - |
Fair Price Momentum | 9.94 EUR |
Fair Price DCF | - |
DBXX Dividends
Dividend Yield 12m | 3.46% |
Yield on Cost 5y | 5.42% |
Annual Growth 5y | 1.98% |
Payout Consistency | 82.1% |
Payout Ratio | % |
DBXX Growth Ratios
Growth Correlation 3m | 69.2% |
Growth Correlation 12m | 66.6% |
Growth Correlation 5y | 93.8% |
CAGR 5y | 9.60% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | 1.08 |
Alpha | -2.70 |
Beta | 0.470 |
Volatility | 14.12% |
Current Volume | 16.3k |
Average Volume 20d | 3.5k |
As of July 05, 2025, the stock is trading at EUR 9.99 with a total of 16,324 shares traded.
Over the past week, the price has changed by -0.74%, over one month by -2.14%, over three months by +8.30% and over the past year by +5.30%.
Yes. Based on ValueRay's Analyses, Xtrackers - FTSE 100 Income (XETRA:DBXX) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.68 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBXX is around 9.94 EUR . This means that DBXX is currently overvalued and has a potential downside of -0.5%.
Xtrackers - FTSE 100 Income has no consensus analysts rating.
According to our own proprietary Forecast Model, DBXX Xtrackers - FTSE 100 Income will be worth about 11.1 in July 2026. The stock is currently trading at 9.99. This means that the stock has a potential upside of +11.51%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 11.1 | 11.5% |